Open-Label, multicenter study of Flecainide Acetate oral inhalation solution for acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm.

Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm – Circulation: Arrythmia & Electrophysiology

Commentary on Twitter

Inhalation of flecainide simply converts many episodes of recent onset atrial fibrillation #AHAJournals #HeartMonthhttps://t.co/vNXx4fKy2u pic.twitter.com/UNGA9DX3qM

— CircEP (@CirculationEP) February 25, 2022